🇺🇸 CRL — Charles River Laboratories International, Inc.

Salud Compra
← Volver

Precio actual

351,87 USD

Máx. histórico

458,30

1866 días

Caída desde máximo

-23,22%

Rango 52 semanas

146,20 – 379,63

Variación hoy

+3,94%

Cierre anterior

338,54

Rango de hoy

339,00 – 356,35

Volumen hoy

1.509.158

Peor caída histórica

-78,23%

24/09/2021 → 11/04/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

35,90%

Información
Nombre completo
Charles River Laboratories International, Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Diagnostics & Research
Empleados
18.300
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
318,87 USD (puede no estar actualizado)
Primera cotización
23/06/2000
Precio actualizado
hace 1 hora
Sobre la empresa

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/03/2001 20,81 20,81 18,00 18,00 -13,46% 13,50% 156.400
09/03/2001 21,90 22,20 20,05 20,80 -4,59% 9,82% 143.400
08/03/2001 21,90 22,65 21,30 21,80 +0,00% 6,16% 50.100
07/03/2001 22,94 23,00 21,50 21,80 -5,01% 6,54% 78.800
06/03/2001 23,35 23,85 22,75 22,95 -1,08% 4,71% 28.100
05/03/2001 23,74 23,85 23,20 23,20 -2,32% 2,74% 16.600
02/03/2001 23,90 24,10 23,61 23,75 -0,25% 2,05% 64.900
01/03/2001 24,20 24,20 23,80 23,81 -1,61% 1,65% 41.200
28/02/2001 24,90 24,95 24,20 24,20 -2,62% 3,01% 44.400
27/02/2001 24,25 25,00 24,25 24,85 +2,69% 3,09% 36.700
26/02/2001 23,15 24,20 23,00 24,20 +4,27% 5,18% 59.200
23/02/2001 23,91 23,91 22,85 23,21 -2,93% 4,43% 15.000
22/02/2001 24,71 24,80 23,90 23,91 -3,20% 3,64% 14.600
21/02/2001 25,10 25,10 24,70 24,70 -1,20% 1,59% 28.300
20/02/2001 24,55 25,38 24,38 25,00 +2,04% 4,07% 16.300
16/02/2001 24,40 24,86 24,40 24,50 +0,00% 1,89% 62.800
15/02/2001 25,00 25,50 24,30 24,50 -1,41% 4,80% 363.500
14/02/2001 25,11 25,54 23,80 24,85 -1,00% 6,93% 508.200
13/02/2001 24,96 25,46 24,96 25,10 +0,60% 2,00% 28.400
12/02/2001 25,20 25,67 24,70 24,95 -1,38% 3,85% 48.600
09/02/2001 26,00 26,00 25,30 25,30 -1,75% 2,69% 34.500
08/02/2001 25,75 25,80 25,70 25,75 +0,00% 0,39% 7.100
07/02/2001 25,96 26,00 25,55 25,75 -0,77% 1,73% 93.600
06/02/2001 25,85 26,10 25,63 25,95 +0,78% 1,82% 71.600
05/02/2001 25,94 26,00 25,51 25,75 +0,00% 1,89% 12.300
02/02/2001 26,05 26,50 24,55 25,75 -0,19% 7,49% 39.300
01/02/2001 28,15 28,15 25,00 25,80 -8,51% 11,19% 117.700
31/01/2001 28,10 28,95 27,80 28,20 +0,36% 4,09% 109.600
30/01/2001 26,00 28,74 26,00 28,10 +8,70% 10,54% 196.300
29/01/2001 25,06 25,90 25,06 25,85 +3,14% 3,35% 59.700